North of Scotland go Live with System C Hospital Electronic Medicines Management

System CThe six NHS health boards across the North of Scotland have gone live with a joint electronic medicines management platform to enhance clinical decision-making and reduce the risk of errors. The first ever multi-locality deployment of System C's pharmacy stock control (PSC) and hospital electronic prescribing medicines administration (HEPMA) systems will benefit over 25,000 staff across 66 hospitals and 5,163 beds.

To better serve the population of nearly 1.4 million people, NHS Grampian, Western Isles, Highland, Tayside, Orkney and Shetland are replacing paper prescriptions and drug charts and existing medication systems with HEPMA. Staff can digitally prescribe and manage medicines on the cloud-based system, which aims to increase legibility and accuracy of prescriptions, reduce time spent on transcription, and provide remote access to patient medication information.

The programme, supported by the Scottish Government, started in March 2020 and was led by a central regional team plus approximately 150 clinical, pharmacy, finance, and digital staff from across the region. The existing PSC systems were replaced by a single integrated PSC from System C in October 2021. This ensured prescribers had the most clinically-appropriate catalogue of medicines available to them and formed the basis of HEPMA. In 2022, the System C team collaborated with the six health teams to design the workflows, set up the system and complete comprehensive user testing, before a staggered HEPMA go-live across all health boards was undertaken between February and November 2023.

The roll out faced challenges including working remotely during the pandemic, geographical challenges with the mix of cities, towns, and remote island locations that create environmental, cultural and practical differences, and individual hospital sites that varied from 3 beds to 885 beds. HEPMA is now deployed to 64% of the region and is scheduled to reach 100% by October 2024.

Heather Binns, North of Scotland HEPMA Senior Programme Manager said: "Embedding a multi-site HEPMA and PSC has never been attempted on this scale before and whilst it was a significant challenge, the regional collaboration brought the collective benefits of sharing knowledge, best practice, and creating new ways of working. This approach delivered greater integration, improved resilience and demonstrated there are substantial benefits for patients and staff to working regionally."

David Pfleger, Director of Pharmacy, NHS Grampian and Senior Responsible Owner for HEPMA, said: "In line with the Government’s aspiration for regional collaboration we wanted to join forces across the six North of Scotland Boards to embed this system once and do it well. It is such an achievement to have 330 wards across 66 hospitals using one medication prescribing and administration system. The benefits the system will bring in terms of medication related safety, standardisation delivered through using a single system and access to medication records by teams operating in different Boards but caring for the same patient are significant and valuable. As the system matures, the paradigm shift it will offer in the availability of data will bring a raft of clinical and corporate governance benefits to support our staff and benefit our patients.

"There will be no more signatures that are difficult to decipher or drug names misspelt and it will be easier to track if and when a patient has had their medication. We also have a better audit trail for reporting and training."

Nick Wilson, CEO at System C said: "We're honoured to have played a pivotal role in the successful implementation of the multi-site HEPMA and PSC system across the North of Scotland. The scale and impact of this programme truly exemplify the transformative power of collaborative efforts. We are thrilled to have been able to contribute to this pioneering initiative and we remain committed to supporting such ambitious and impactful projects in the future."

About System C

System C is a British technology company that has supports over 700,000 users across 400 customers, in the NHS, private healthcare and social care across the UK and other geographies.

Our healthcare platform, CareFlow, offers the most extensive range of Electronic Patient Record (EPR) capabilities available. System C’s team brings a wealth of experience in helping trusts select the right product choice and configuration to deliver optimum benefits and ROI, ensuring both best-fit product guidance and post-implementation support. These technologies integrate with existing systems, streamline workflows and refine processes across all care settings. Beyond meeting the specific standards and digital maturity assessments, we can also deliver a digital maturity roadmap for organisations aiming for HIMSS Level 7.

Our social care platform, Liquidlogic, is the market leader in the domains of social care and education. With best-in class capabilities across Adults and Children's social care, it offers a framework for configurability that can be adapted to meet a local authorities social care and educational needs whilst delivering full financial transparency. Our Social Care and Education team, enriched with hands-on social care and education experience, stands testament to our commitment to creating practitioner-focused solutions.

At the heart of System C is our enduring mission: delivering technology with the power to connect and transform health, social care and education outcomes for all. We're more than just a technology provider; we're a partner in transformation, committed to the well-being and advancement of the communities we serve.

For more information, visit www.systemc.com

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...